Lifeline Biotechnologies is selling at 1.0E-4 as of the 26th of January 2025; that is 50 percent decrease since the beginning of the trading day. The stock's open price was 2.0E-4. Lifeline Biotechnologies has less than a 19 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. The performance scores are derived for the period starting the 27th of December 2024 and ending today, the 26th of January 2025. Click here to learn more.
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Lifeline Biotechnologies, Inc. is headquartered in Reno, Nevada. Lifeline Biotech operates under Medical Devices classification in the United States and is traded on OTC Exchange. More on Lifeline Biotechnologies
Lifeline Biotechnologies [LLBO] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lifeline Biotechnologies's market, we take the total number of its shares issued and multiply it by Lifeline Biotechnologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lifeline Biotechnologies conducts business under Healthcare sector and is part of Medical Devices industry.
Check Lifeline Biotechnologies Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Lifeline Biotechnologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Earnings Calls Now
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Other Information on Investing in Lifeline Pink Sheet
Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.